Journals / Turkish Journal of Pharmaceutical Sciences / 2018 / Cilt: 15 - Sayı: 1

Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and In Vitro Evaluation

Doğrudan Basım ile Hazırlanan Ambroksol Hidroklorür ve Salbutamol Sülfat İçeren Sabit Doz Kombinasyonu Oral-dağılan Tabletler: Formülasyon Tasarımı, Geliştirilmesi ve İn Vitro Değerlendirilmesi

Pages
29–37
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The accelerated stability study shows that formulation is quite stable at normal temperature and humidity conditions as wellas at extreme temperature conditions.Conclusion: By adopting a systematic formulation approach, ODTs of AMB hydrochloride and salbutamol sulphate in fixed-dose combination canbe formulated using superdisintegrants in combination with appropriate binder and excipients; this was found to be economical and industriallyfeasible.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To design a formulation and develop ODTs of AMB hydrochloride and salbutamol sulphate in combination for the treatment of respiratorydisorders and perform an in vitro evaluation using superdisintegrants in combination with a suitable binder and excipients.
📊
Key Findings & Data:Different concentrations of MCC and PVP K-30 were also studied along with the optimized SSG concentration.The tablets were evaluated for hardness, friability, weight variation, wetting time, in vitro DT, and percentage drug content uniformity.
💡
Conclusion & Impact:The accelerated stability study shows that formulation is quite stable at normal temperature and humidity conditions as wellas at extreme temperature conditions.Conclusion: By adopting a systematic formulation approach, ODTs of AMB hydrochloride and salbutamol sulphate in fixed-dose combination canbe formulated using superdisintegrants in combination with appropriate binder and excipients; this was found to be economical and industriallyfeasible.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To design a formulation and develop ODTs of AMB hydrochloride and salbutamol sulphate in combination for the treatment of respiratorydisorders and perform an in vitro evaluation using superdisintegrants in combination with a suitable binder and excipients. Direct compression wasused to prepare the tablets.Materials and Methods: In the present research work, different concentrations of SSG as a superdisintegrant were used to optimize the concentrationof SSG in the formulation of ODTs. Different concentrations of MCC and PVP K-30 were also studied along with the optimized SSG concentration.The tablets were evaluated for hardness, friability, weight variation, wetting time, in vitro DT, and percentage drug content uniformity. The optimizedformulation was further evaluated in an in vitro release study, and drug-excipient compatibility and accelerated stability study.Results: The optimized concentration of SSG was found as 4% on the basis of the lowest DT. The 1% concentration of MCC was selected as theoptimum binder concentration on the basis of the lowest DT. ODTs passed all the quality control tests viz., weight variation, hardness, friability, invitro DT, drug content (%) and wetting time. The formulation satisfied the requirements of the FDA for rapid-dissolving tablets and allowed morethan 85% drug to be released within 30 min. The fourier transform infrared spectroscopy study revealed that there was no interaction between thedrug and excipients. The accelerated stability study shows that formulation is quite stable at normal temperature and humidity conditions as wellas at extreme temperature conditions.Conclusion: By adopting a systematic formulation approach, ODTs of AMB hydrochloride and salbutamol sulphate in fixed-dose combination canbe formulated using superdisintegrants in combination with appropriate binder and excipients; this was found to be economical and industriallyfeasible.

Özet

Amaç: Solunum bozukluklarının tedavisi için oral-dağılan AMB hidroklorür ve salbutamol sülfat kombinasyon tabletlerinin (ODT) geliştirilmesi ve kombine süper dağıtıcıların uygun bağlayıcı ve eksipiyanlar ile kombine kullanımı ile in vitro değerlendirmenin yapılmasıdır. Tabletleri hazırlamak için doğrudan basım kullanıldı. Gereç ve Yöntemler: Bu araştırmada, oral dağılan tabletlerin formülasyonunda SNG konsantrasyonunu optimize etmek için farklı SNG konsantrasyonları süper dağıtıcı olarak kullanıldı. Farklı konsantrasyonlarda MCC ve PVP K-30 da optimize SNG konsantrasyonu ile birlikte çalışıldı. Tabletler, sertlik,kırılganlık, ağırlık değişimi, ıslanma süresi, in vitro dağılma süresi ve yüzde etken madde içerik tekdüzeliği açısından değerlendirildi. Optimize edilmiş formülasyon ayrıca in vitro salım çalışması ve etken madde-eksipiyan geçimliliği ve hızlandırılmış stabilite çalışmasıyla değerlendirildi. Bulgular: En düşük dağılma süresine dayanarak SNG’nin optimum konsantrasyonu, %4 olarak bulundu. MCC’nin %1 konsantrasyonu, en düşük dağılma süresine dayanarak optimum bağlayıcı konsantrasyonu olarak seçildi. Oral dağılan tabletler, ağırlık değişimi, sertlik, kırılganlık, in vitro dağılma süresi, etken madde içeriği (%) ve ıslanma süresi gibi tüm kalite kontrol testlerini geçti. Formülasyon, hızlı çözünen tabletler için FDA şartlarını yerine getirdi ve %85’den fazla etken maddenin 30 dakika içinde salımını sağladı. Fourier dönüşümü kızıl ötesi spektroskopi çalışması, etken madde ve eksipiyanlar arasında herhangi bir etkileşimin olmadığını ortaya koymuştur. Hızlandırılmış stabilite çalışması, normal sıcaklık ve nem koşullarında ve aşırı sıcaklık koşullarında formülasyonun oldukça kararlı olduğunu göstermektedir. Sonuç: Sistematik bir formülasyon yaklaşımı benimseyerek, sabit doz kombinasyonundaki AMB hidroklorür ve salbutamol sülfat ODT’leri, süper dağıtıcıların uygun bağlayıcı ve eksipiyanlar ile kombinasyonu kullanılarak formüle edilebilir; bunun ekonomik ve endüstriyel olarak uygulanabilir olduğu bulunmuştur.

🔖

Cite This Article

SINGH, G., SHARMA, D., SINGH, R. (2022). Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and In Vitro Evaluation. Turkish Journal of Pharmaceutical Sciences, Cilt: 15 - Sayı: 1, 29–37. https://ajindex.com/articles/613832

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Brniak W, Jachowicz R, Pelka P. The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs). Saudi Pharm J. 2015;23:437-443
  2. Pawar H, Varkhade C, Jadhav P, Mehra, K. Development and evaluation of orodispersible tablets using a natural polysaccharide isolated from Cassia tora seeds. Integ Med Res. 2014;3:91-98
  3. Munoz H, Castan H, Clares B, Ruiz MA. Obtaining fast dissolving disintegrating tablets with different doses of melatonin. Int J Pharm. 2014;467:84-89
  4. Kaur L, Bala R, Kanojia N, Nagpal M, Dhingra GA. Formulation development and optimization of fast dissolving tablets of aceclofenac using natural superdisintegrant. ISRN Pharm. 2014;2014:242504
  5. Remya K, Beena P, Bijesh P, Sheeba A. Formulation development, evaluation and comparative study of effects of super disintegrants in cefixime oral disintegrating tablets. J Young Pharm. 2010;2:234-239
  6. Segale L, Maggi L, Machiste EO, Conti S, Conte U, Grenier A, Bess C. Formulation design and development to produce orodispersible tablets by direct compression. J Drug Del Sci Tech. 2007;17:199-203
  7. Bankar A, Bankar VH, Gaikwad PD, Pawar SP. Formulation design and optimization of sustained release tablet of ambroxol hydrochloride. Int J Drug Del. 2012;4:375-385
  8. Aher SS, Songire PR, Saudagar RB. Formulation and evaluation of controlled release matrix tablet of albuterol sulphate. Int J Curr Res. 2016;8:35044-35050
  9. Comoglu T, Unal B. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug. Pharm Dev Technol. 2015;20:60-64
  10. Malvey S, Kshirasagar N, Vishnu YV, Srikanth J. Formulation and evaluation of acyclovir orodispersible tablets using sublimation method. J Gen Pract. 2015;3:208
  11. Sharma D, Singh M, Kumar D, Singh G. Formulation development and evaluation of fast disintegrating tablet of salbutamol sulphate: A novel drug delivery for pediatrics and geriatrics. J Pharm. 2014;1-8
  12. Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm. 2009;73:162-171
  13. Sharma D, Singh M, Kumar D, Singh G, Rathore MS. Formulation development and evaluation of fast disintegrating tablets of ambroxol hydrochloride for pediatrics-A novel approach for drug delivery. Indian J Pharma Edu Res. 2014;48:40-48
  14. Bala R, Khanna S, Pawar PK. Formulation and optimization of fast dissolvin